Sutro Biopharma
STRO
STRO
101 hedge funds and large institutions have $39.7M invested in Sutro Biopharma in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
-12
Holders Change %
-10.62%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
22
Reduced
24
Closed
43
Calls
$41K
Puts
–
Net Calls
+$41K
Net Calls Change
+$33K
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.88M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.69M |
| 3 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.45M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.1M |
| 5 |
Jane Street
New York
|
+$492K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.93M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.89M |
| 3 |
State Street
Boston,
Massachusetts
|
-$956K |
| 4 |
Goldman Sachs
New York
|
-$933K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$766K |
